<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id>
      <journal-title-group>
        <journal-title>Diagnostic Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-1596</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23651629</article-id>
      <article-id pub-id-type="pmc">3652771</article-id>
      <article-id pub-id-type="publisher-id">1746-1596-8-74</article-id>
      <article-id pub-id-type="doi">10.1186/1746-1596-8-74</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: a case report and review of the literature</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="A1">
          <name>
            <surname>Meguro</surname>
            <given-names>Shiori</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>megu_s@saitama-med.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A2">
          <name>
            <surname>Yasuda</surname>
            <given-names>Masanori</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>m_yasuda@saitama-med.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Shimizu</surname>
            <given-names>Michio</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>shimizu@saitama-med.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Kurosaki</surname>
            <given-names>Akira</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>akirak@saitama-med.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Fujiwara</surname>
            <given-names>Keiichi</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>fujiwara@saitama-med.ac.jp</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Departments of Pathology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama, 350-1128, Japan</aff>
      <aff id="I2"><label>2</label>Departments of Gynecologic Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama, 350-1128, Japan</aff>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>7</day>
        <month>5</month>
        <year>2013</year>
      </pub-date>
      <volume>8</volume>
      <fpage>74</fpage>
      <lpage>74</lpage>
      <history>
        <date date-type="received">
          <day>4</day>
          <month>2</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>4</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2013 Meguro et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Meguro et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.diagnosticpathology.org/content/8/1/74"/>
      <abstract>
        <sec>
          <title>Abstract</title>
          <p>Carcinosarcoma of the uterine cervix is less common than its counterpart in the uterine corpus. On the other hand, mesonephric adenocarcinoma is also a rare neoplasm in the uterine cervix, and it has been reported that mesonephric adenocarcinomas are often accompanied by sarcomatous components. We present a case of mesonephric adenocarcinoma with a sarcomatous component which arose in a 63-year-old postmenopausal woman. The hysterectomy specimen grossly showed an exophytic mass measuring 1.8&#xA0;cm in the uterine cervix. Histologically, diffuse mesonephric hyperplasia and adenocarcinoma with malignant spindle cell proliferation was recognized, and therefore the tumor was diagnosed as &#x201C;mesonephric adenocarcinoma with a sarcomatous component.&#x201D; The review of the literature of cervical carcinosarcoma and cervical mesonephric adenocarcinoma revealed that 16% of cervical carcinosarcoma is of mesonephric duct origin, and that mesonephric adenocarcinoma seems to be more likely to have sarcomatous change. We think the presence of a sarcomatous component in the cervical biopsy specimen could be helpful in the diagnosis of mesonephric duct origin.</p>
        </sec>
        <sec>
          <title>Virtual slides</title>
          <p>The virtual slide(s) for this article can be found here: <ext-link ext-link-type="uri" xlink:href="http://www.diagnosticpathology.diagnomx.eu/vs/1243996503911062">http://www.diagnosticpathology.diagnomx.eu/vs/1243996503911062</ext-link></p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Mesonephric adenocarcinoma</kwd>
        <kwd>Carcinosarcoma</kwd>
        <kwd>Uterine cervix</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Carcinosarcoma is the neoplasm composed of malignant epithelial and mesenchymal components, and a mesenchymal component of carcinosarcoma is recently considered as a metaplastic change of carcinoma. Carcinosarcoma arises less frequently in the uterine cervix and the vulva, than in the uterine corpus [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Although not much attention has been paid to it, cervical carcinosarcoma can be characterized by having two different origins: the M&#xFC;llerian ducts and the mesonephric duct remnants [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B7">7</xref>]. Mesonephric adenocarcinoma arises from mesonephric duct remnants. Unlike the usual endocervical-type adenocarcinoma, it is known that mesonephric adenocarcinoma is not related to human papillomavirus (HPV) infection [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref>]. We present a case of mesonephric adenocarcinoma with a sarcomatous component arising from mesonephric hyperplasia of the uterine cervix, and comprehensively review the literature of the cervical carcinosarcoma arising from M&#xFC;llerian ducts and mesonephric ducts.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 63-year-old, Japanese postmenopausal woman with abnormal vaginal bleeding consulted our hospital. MR imaging showed an enhanced uterine cervical mass measuring 2.0&#xA0;cm in diameter. There was no evidence of lymphadenopathy or metastasis. The cervical biopsy specimen showed diffuse malignant spindle cell proliferation with myxoid stroma. The tumor cells were focally arranged in small nests or glands, resulting in a diagnosis of undifferentiated carcinoma. The patient underwent radical hysterectomy, bilateral salpingo-oophorectomy, and pelvic lymphadenectomy, without adjuvant chemotherapy. Seven months after the operation, the patient was treated by chemoradiative therapy because of local recurrence, and the recurrent tumor disappeared after three months of the therapy.</p>
      <p>The hysterectomy specimen grossly showed an exophytic mass in the left lateral wall of the cervix, measuring 1.8&#xA0;cm (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>). Microscopically, mesonephric hyperplasia of the diffuse type (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref>) extended to the entire circumferences of the cervix, and a small number of mesonephric tubules were found in the vagina and myometrium. In the adjacent area of mesonephric hyperplasia, adenocarcinoma composed of small irregular glands was observed. Compared to hyperplasia, these irregular glands had severe cytological atypia (Figure&#xA0;<xref ref-type="fig" rid="F3">3</xref>). Papillary pattern and ductal pattern were also present (Figure&#xA0;<xref ref-type="fig" rid="F4">4</xref>). Furthermore, a sarcomatous component composed of polygonal and spindle-shaped cells was recognized (Figure&#xA0;<xref ref-type="fig" rid="F5">5</xref>), and there was a transition from the adenocarcinomatous component to the sarcomatous component (Figure&#xA0;<xref ref-type="fig" rid="F6">6</xref>). No heterologous component was noted. The sarcomatous component was interpreted as undifferentiated carcinoma as in the previous biopsy specimen. The results of the immunohistochemical study are shown in Table&#xA0;<xref ref-type="table" rid="T1">1</xref>. Based on these findings, the diagnosis of mesonephric adenocarcinoma with a sarcomatous component arising in mesonephric hyperplasia was finally confirmed, being staged at pT2a because of minimal invasion of the adenocarcinoma into the vaginal wall.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Loupe view of the uterine cervical tumor.</bold> The tumor showed exophytic polypoid growth. The area of hyperplasia (enclosed by the dotted line) covered about 20% of the lesion, and the adenocarcinoma area (solid line) covered about 40%. The carcinosarcoma component (unenclosed area of the polypoid lesion) accounted for about 40%.</p>
        </caption>
        <graphic xlink:href="1746-1596-8-74-1"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>The microscopic view of mesonephric hyperplasia.</bold> In mesonephric hyperplasia, the cytological atypia was bland and mitotic figures were rarely seen.</p>
        </caption>
        <graphic xlink:href="1746-1596-8-74-2"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p><bold>Mesonephric adenocarcinoma in the adjacent area of mesonephric hyperplasia.</bold> The adenocarcinoma cells were arranged as small irregular glands.</p>
        </caption>
        <graphic xlink:href="1746-1596-8-74-3"/>
      </fig>
      <fig id="F4" position="float">
        <label>Figure 4</label>
        <caption>
          <p><bold>Mesonephric adenocarcinoma with papillary and ductal structures.</bold> Papillary and ductal patterns were also observed in a part of the adenocarcinoma component.</p>
        </caption>
        <graphic xlink:href="1746-1596-8-74-4"/>
      </fig>
      <fig id="F5" position="float">
        <label>Figure 5</label>
        <caption>
          <p><bold>The sarcomatous component.</bold> The sarcomatous component was composed of spindle cell proliferation.</p>
        </caption>
        <graphic xlink:href="1746-1596-8-74-5"/>
      </fig>
      <fig id="F6" position="float">
        <label>Figure 6</label>
        <caption>
          <p>A transition between the carcinomatous component and the sarcomatous component.</p>
        </caption>
        <graphic xlink:href="1746-1596-8-74-6"/>
      </fig>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Antibodies used for immunohistochemical staining and its results</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left" valign="bottom">
                <bold>Antigen</bold>
                <hr/>
              </th>
              <th colspan="3" align="center" valign="bottom">
                <bold>Antibodies</bold>
                <hr/>
              </th>
              <th colspan="3" align="center" valign="bottom">
                <bold>Results</bold>
                <hr/>
              </th>
            </tr>
            <tr>
              <th align="center" valign="bottom">&#xA0;<hr/></th>
              <th align="left" valign="bottom">
                <bold>Clone</bold>
                <hr/>
              </th>
              <th align="left" valign="bottom">
                <bold>Source</bold>
                <hr/>
              </th>
              <th align="left" valign="bottom">
                <bold>Dilution</bold>
                <hr/>
              </th>
              <th align="center" valign="bottom">
                <bold>Biopsy</bold>
                <hr/>
              </th>
              <th colspan="2" align="center" valign="bottom">
                <bold>Hysterectomy</bold>
                <hr/>
              </th>
            </tr>
            <tr>
              <th align="center">&#xA0;</th>
              <th align="center">&#xA0;</th>
              <th align="center">&#xA0;</th>
              <th align="center">&#xA0;</th>
              <th align="center">&#xA0;</th>
              <th align="center">
                <bold>Adenoca.</bold>
              </th>
              <th align="center">
                <bold>Sarscomatous component</bold>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="left" valign="bottom">AE1/AE3<hr/></td>
              <td align="left" valign="bottom">AE1/AE3<hr/></td>
              <td align="left" valign="bottom">Dako, Glostrup, Denmark<hr/></td>
              <td align="left" valign="bottom">1: 50<hr/></td>
              <td align="center" valign="bottom">+<hr/></td>
              <td align="center" valign="bottom">+++<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">CAM5.2<hr/></td>
              <td align="left" valign="bottom">CAM5.2<hr/></td>
              <td align="left" valign="bottom">BD Biosciences, California, USA<hr/></td>
              <td align="left" valign="bottom">1: 2<hr/></td>
              <td align="center" valign="bottom">ND*<hr/></td>
              <td align="center" valign="bottom">+++<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">vimentin<hr/></td>
              <td align="left" valign="bottom">V9<hr/></td>
              <td align="left" valign="bottom">Dako<hr/></td>
              <td align="left" valign="bottom">1: 100<hr/></td>
              <td align="center" valign="bottom">+++<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">+++<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">ER<hr/></td>
              <td align="left" valign="bottom">SP1<hr/></td>
              <td align="left" valign="bottom">Roche Diagnostics, Basel, Switzerland<hr/></td>
              <td align="left" valign="bottom">1: 1<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">PgR<hr/></td>
              <td align="left" valign="bottom">1E2<hr/></td>
              <td align="left" valign="bottom">Roche Diagnostics<hr/></td>
              <td align="left" valign="bottom">1: 1<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">AR<hr/></td>
              <td align="left" valign="bottom">AR441<hr/></td>
              <td align="left" valign="bottom">Dako<hr/></td>
              <td align="left" valign="bottom">1: 50<hr/></td>
              <td align="center" valign="bottom">ND*<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">CD10<hr/></td>
              <td align="left" valign="bottom">56C6<hr/></td>
              <td align="left" valign="bottom">Leica Microsystems, Newcastle, UK<hr/></td>
              <td align="left" valign="bottom">1: 40<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">++<hr/></td>
              <td align="center" valign="bottom">++<hr/></td>
            </tr>
            <tr>
              <td align="left">calretinin</td>
              <td align="left">5A5</td>
              <td align="left">Leica Microsystems</td>
              <td align="left">1: 100</td>
              <td align="center">-</td>
              <td align="center">+</td>
              <td align="center">-</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>ND*, not done.</p>
          <p>Immunopositivity was semi-quantitatively assessed as follows: 3+, more than 10% of the tumor cells positive; 2+, 1-10% of the tumor cells positive; 1+, less than 1% tumor cells positive; no tumor cell staining was considered negative.</p>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>The mesonephric ducts run parallel to the M&#xFC;llerian ducts in the fetus, and regress as female development progresses [<xref ref-type="bibr" rid="B11">11</xref>]. Mesonephric remnants are detected by chance in the lateral wall of the vagina and uterus, the broad ligament, the mesosalpinx, or the ovarian hilus, and occur at a frequency of about 20% in the adult uterine cervix [<xref ref-type="bibr" rid="B12">12</xref>]. The remnants sometimes become hyperplastic, and rarely mesonephric adenocarcinoma can develop with the background of remnants or hyperplasia.</p>
      <p>The present case was characterized by the presence of a sarcomatous component. In the biopsy specimen, because only a spindled cell component was obtained, the tumor was initially diagnosed as &#x201C;undifferentiated carcinoma.&#x201D; In the previous literature, differential diagnoses of mesonephric adenocarcinoma included clear cell adenocarcinoma, endometrioid adenocarcinoma, serous adenocarcinoma, usual endocervical-type adenocarcinoma, and minimal deviation adenocarcinoma [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. However, it was not until recently that attention has been paid to the presence of a sarcomatous component as a helpful tool in the differential diagnosis of mesonephric adenocarcinoma.</p>
      <p>Including the present case, 42 cases with mesonephric adenocarcinoma of the uterine cervix have been reported in the English literature. Ten out of the 42 cases (24%) had a sarcomatous component (Table&#xA0;<xref ref-type="table" rid="T2">2</xref>) [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B7">7</xref>]. Regarding these 10 cases, the mean occurrence age was 54&#xA0;years; tumor size ranged from 1.8 to 8.0&#xA0;cm (mean 4.5) in the largest diameter; and 4 of the tumors were grossly exophytic or polypoid lesions [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. The sarcomatous components were as follows: spindle cell sarcoma in 6 cases [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B5">5</xref>]; osteosarcoma in 2 cases [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>]; chondrosarcoma in 1 case [<xref ref-type="bibr" rid="B4">4</xref>]; rhabdomyosarcoma in 1 case [<xref ref-type="bibr" rid="B4">4</xref>].</p>
      <table-wrap position="float" id="T2">
        <label>Table 2</label>
        <caption>
          <p>Mesonephric tumors with a sarcomatous component</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
            <col align="left"/>
            <col align="left"/>
            <col align="center"/>
            <col align="left"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="center">
                <bold>Case</bold>
              </th>
              <th align="center">
                <bold>Source (ref no.)</bold>
              </th>
              <th align="center">
                <bold>Age (year)</bold>
              </th>
              <th align="center">
                <bold>Size (cm)</bold>
              </th>
              <th align="left">
                <bold>Pathological diagnosis</bold>
              </th>
              <th align="left">
                <bold>Heterologous component</bold>
              </th>
              <th align="center">
                <bold>FIGO stage</bold>
              </th>
              <th align="left">
                <bold>Outcome</bold>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="center" valign="bottom">1<hr/></td>
              <td align="center" valign="bottom">Present case<hr/></td>
              <td align="center" valign="bottom">63<hr/></td>
              <td align="center" valign="bottom">1.8<hr/></td>
              <td align="left" valign="bottom">Mesonephric adenoca. with spindle cell component<hr/></td>
              <td align="left" valign="bottom">No<hr/></td>
              <td align="center" valign="bottom">IIA<hr/></td>
              <td align="left" valign="bottom">NED 10 mo<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">2<hr/></td>
              <td align="center" valign="bottom">3<hr/></td>
              <td align="center" valign="bottom">37<hr/></td>
              <td align="center" valign="bottom">ND<hr/></td>
              <td align="left" valign="bottom">Mesonephric adenoca. with spindle cell component<hr/></td>
              <td align="left" valign="bottom">No<hr/></td>
              <td align="center" valign="bottom">IB<hr/></td>
              <td align="left" valign="bottom">AWD 11&#xA0;yr<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">3<hr/></td>
              <td align="center" valign="bottom">3<hr/></td>
              <td align="center" valign="bottom">40<hr/></td>
              <td align="center" valign="bottom">ND<hr/></td>
              <td align="left" valign="bottom">Mesonephric adenoca. with spindle cell component<hr/></td>
              <td align="left" valign="bottom">No<hr/></td>
              <td align="center" valign="bottom">IB<hr/></td>
              <td align="left" valign="bottom">NED 2.3&#xA0;yr<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">4<hr/></td>
              <td align="center" valign="bottom">3<hr/></td>
              <td align="center" valign="bottom">73<hr/></td>
              <td align="center" valign="bottom">ND<hr/></td>
              <td align="left" valign="bottom">Mesonephric adenoca. with spindle cell component<hr/></td>
              <td align="left" valign="bottom">No<hr/></td>
              <td align="center" valign="bottom">IB<hr/></td>
              <td align="left" valign="bottom">NED 3&#xA0;yr<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">5<hr/></td>
              <td align="center" valign="bottom">4<hr/></td>
              <td align="center" valign="bottom">54<hr/></td>
              <td align="center" valign="bottom">6<hr/></td>
              <td align="left" valign="bottom">Malignant mixed mesonephric tumor<hr/></td>
              <td align="left" valign="bottom">No<hr/></td>
              <td align="center" valign="bottom">IIA<hr/></td>
              <td align="left" valign="bottom">DOD 7 mo<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">6<hr/></td>
              <td align="center" valign="bottom">5<hr/></td>
              <td align="center" valign="bottom">ND<hr/></td>
              <td align="center" valign="bottom">ND<hr/></td>
              <td align="left" valign="bottom">Mesonephric adenoca. With spindle cell component<hr/></td>
              <td align="left" valign="bottom">No<hr/></td>
              <td align="center" valign="bottom">ND<hr/></td>
              <td align="left" valign="bottom">ND<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">7<hr/></td>
              <td align="center" valign="bottom">3, 6<hr/></td>
              <td align="center" valign="bottom">39<hr/></td>
              <td align="center" valign="bottom">ND<hr/></td>
              <td align="left" valign="bottom">Mesonephric adenoca. with spindle cell component<hr/></td>
              <td align="left" valign="bottom">Osteosarcoma<hr/></td>
              <td align="center" valign="bottom">IB<hr/></td>
              <td align="left" valign="bottom">DOD 6.2&#xA0;yr<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">8<hr/></td>
              <td align="center" valign="bottom">7<hr/></td>
              <td align="center" valign="bottom">65<hr/></td>
              <td align="center" valign="bottom">3<hr/></td>
              <td align="left" valign="bottom">Osteosarcoma associated with mesonephric rests<hr/></td>
              <td align="left" valign="bottom">Osteosarcoma<hr/></td>
              <td align="center" valign="bottom">IB<hr/></td>
              <td align="left" valign="bottom">NED 1&#xA0;yr 11mo<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">9<hr/></td>
              <td align="center" valign="bottom">4<hr/></td>
              <td align="center" valign="bottom">54<hr/></td>
              <td align="center" valign="bottom">3.5<hr/></td>
              <td align="left" valign="bottom">Malignant mixed mesonephric tumor<hr/></td>
              <td align="left" valign="bottom">Chondrosarcoma<hr/></td>
              <td align="center" valign="bottom">IB<hr/></td>
              <td align="left" valign="bottom">NED 1&#xA0;yr 1mo<hr/></td>
            </tr>
            <tr>
              <td align="center">10</td>
              <td align="center">4</td>
              <td align="center">62</td>
              <td align="center">8</td>
              <td align="left">Malignant mixed mesonephric tumor</td>
              <td align="left">Rhabdomyosarcoma</td>
              <td align="center">IVB</td>
              <td align="left">AWD 3&#xA0;yr 3mo</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>ND, not described; adenoca., adenocarcinoma; NED, no evidence of disease; AWD, alive with disease; DOD, dead of disease.</p>
        </table-wrap-foot>
      </table-wrap>
      <p>On the other hand, including this case, 61 cases of cervical carcinosarcoma have been reported in the English literature. Of these, 10 cases (16%) were of mesonephric duct origin, and 51 cases (85%) were of M&#xFC;llerian duct origin, traditionally designated as malignant M&#xFC;llerian mixed tumor (MMMT). Regarding the epithelial component of MMMT, adenocarcinoma and squamous cell carcinoma were recognized with approximately the same frequency. Basaloid carcinoma, adenoid basal carcinoma, and adenoid cystic carcinoma were also observed in a few cases. Carcinosarcoma is an extremely rare tumor of the uterine cervix. However, from the point view of mesonephric duct origin, one-quarter of them have a sarcomatous component, and they account for 16% of cervical carcinosarcoma. These values may represent an overestimate since these are more likely than the M&#xFC;llerian variants to be reported in the literature. Even so, interestingly, it seems that mesonephric adenocarcinoma is more likely to have sarcomatous change than the usual uterine cervical carcinoma arising from M&#xFC;llerian ducts.</p>
      <p>In the present case, the cervical tumor was initially diagnosed as &#x201C;undifferentiated carcinoma&#x201D; in the biopsy. Mesonephric adenocarcinomas are usually difficult to make a correct diagnosis by small specimen of biopsy because of their common occurrence site of the deep and lateral wall of the uterine cervix. In addition, mesonephric adenocarcinomas are known immunohistochemically to express CD10, calretinin, and androgen receptor [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>], but these immunohistochemical profiles have not been evaluated enough in the sarcomatous component. Considering that 16% of cervical carcinosarcoma is of mesonephric duct origin, if a sarcomatous component is recognized in the biopsy specimen, it may be suspected of being of mesonephric duct origin.</p>
      <p>As with cervical squamous cell carcinoma, the association between cervical adenocarcinoma of the usual type and HPV infection is well known [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B17">17</xref>]. However mesonephric adenocarcinoma is not related to HPV infection [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref>]. Although an HPV test was not performed in the present case, the tumor is predicted to be HPV-negative.</p>
      <p>Looking at Table&#xA0;<xref ref-type="table" rid="T2">2</xref>, 2 cases (22%) died [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B6">6</xref>]; 2 cases (22%) were alive with metastatic or local recurrent tumor [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]; and 5 cases (56%) were free of disease [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. In contrast, in the cases of mesonephric adenocarcinoma without a sarcomatous component, 20% of cases died of the disease [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>]. It seems that there is no significant difference in the prognosis between mesonephric adenocarcinoma with and without a sarcomatous component, although it has been previously reported that mesonephric adenocarcinoma with a sarcomatous component showed aggressive behavior [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B21">21</xref>].</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusion</title>
      <p>We presented a case of mesonephric adenocarcinoma with a sarcomatous component arising from mesonephric hyperplasia of the uterine cervix. It seems that mesonephric adenocarcinoma is more likely to have sarcomatous change. Mesonephric adenocarcinomas are difficult to make a correct diagnosis by small biopsy specimens; however, the presence of a sarcomatous component could be helpful in the diagnosis of mesonephric duct origin. Regarding the relation between the sarcomatous component and prognosis, further studies are needed.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>SM drafted the manuscript. MY conducted the reporting method of the present case. MS helped to draft the manuscript. AK and KF analyzed the clinical information as gynecological oncologists. All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="book">
          <name>
            <surname>McCluggage</surname>
            <given-names>WG</given-names>
          </name>
          <name>
            <surname>Kubik-Huch</surname>
            <given-names>RA</given-names>
          </name>
          <person-group person-group-type="editor">Tavassoli FA, Devilee P</person-group>
          <article-title>Mixed epithelial and mesenchymal tumours</article-title>
          <source>World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs</source>
          <year>2003</year>
          <publisher-name>Lyon: IARC Press</publisher-name>
          <fpage>284</fpage>
          <lpage>286</lpage>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Petrillo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Corrado</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Carbone</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Macchia</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Ferrandina</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Vulvar squamous cell carcinoma with sarcoma-like stroma: a case report and review of the literature</article-title>
          <source>Diagn Pathol</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>95</fpage>
          <pub-id pub-id-type="doi">10.1186/1746-1596-6-95</pub-id>
          <pub-id pub-id-type="pmid">21961623</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Clement</surname>
            <given-names>PB</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>RH</given-names>
          </name>
          <name>
            <surname>Keh</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Ost&#xF6;r</surname>
            <given-names>AG</given-names>
          </name>
          <name>
            <surname>Scully</surname>
            <given-names>RE</given-names>
          </name>
          <article-title>Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component</article-title>
          <source>Am J Surg Pathol</source>
          <year>1995</year>
          <volume>19</volume>
          <fpage>1158</fpage>
          <lpage>1171</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-199510000-00006</pub-id>
          <pub-id pub-id-type="pmid">7573674</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bagu&#xE9;</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rodr&#xED;guez</surname>
            <given-names>IM</given-names>
          </name>
          <name>
            <surname>Prat</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>2004</year>
          <volume>28</volume>
          <fpage>601</fpage>
          <lpage>607</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200405000-00006</pub-id>
          <pub-id pub-id-type="pmid">15105647</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kenny</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>McBride</surname>
            <given-names>HA</given-names>
          </name>
          <name>
            <surname>Jamison</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>McCluggage</surname>
            <given-names>WG</given-names>
          </name>
          <article-title>Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-&#x3B2;</article-title>
          <source>Am J Surg Pathol</source>
          <year>2012</year>
          <volume>36</volume>
          <fpage>799</fpage>
          <lpage>807</lpage>
          <pub-id pub-id-type="doi">10.1097/PAS.0b013e31824a72c6</pub-id>
          <pub-id pub-id-type="pmid">22456609</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Silver</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Devouassoux-Shisheboran</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mezzetti</surname>
            <given-names>TP</given-names>
          </name>
          <name>
            <surname>Tavassoli</surname>
            <given-names>FA</given-names>
          </name>
          <article-title>Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings</article-title>
          <source>Am J Surg Pathol</source>
          <year>2001</year>
          <volume>25</volume>
          <fpage>379</fpage>
          <lpage>387</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200103000-00013</pub-id>
          <pub-id pub-id-type="pmid">11224609</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bloch</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Roth</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Stehman</surname>
            <given-names>FB</given-names>
          </name>
          <name>
            <surname>Hull</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Schwenk</surname>
            <given-names>GR</given-names>
            <suffix>Jr</suffix>
          </name>
          <article-title>Osteosarcoma of the uterine cervix associated with hyperplastic and atypical mesonephric rests</article-title>
          <source>Cancer</source>
          <year>1988</year>
          <volume>62</volume>
          <fpage>1594</fpage>
          <lpage>1600</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19881015)62:8&lt;1594::AID-CNCR2820620823&gt;3.0.CO;2-Y</pub-id>
          <pub-id pub-id-type="pmid">3048632</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Pirog</surname>
            <given-names>EC</given-names>
          </name>
          <name>
            <surname>Kleter</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Olgac</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bobkiewicz</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lindeman</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Quint</surname>
            <given-names>WG</given-names>
          </name>
          <name>
            <surname>Richart</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Isacson</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma</article-title>
          <source>Am J Pathol</source>
          <year>2000</year>
          <volume>157</volume>
          <fpage>1055</fpage>
          <lpage>1062</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9440(10)64619-6</pub-id>
          <pub-id pub-id-type="pmid">11021808</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Houghton</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Jamison</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Carson</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>McCluggage</surname>
            <given-names>WG</given-names>
          </name>
          <article-title>p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection</article-title>
          <source>Histopathology</source>
          <year>2010</year>
          <volume>57</volume>
          <fpage>342</fpage>
          <lpage>350</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2559.2010.03632.x</pub-id>
          <pub-id pub-id-type="pmid">20727021</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Park</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Kiyokawa</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Soslow</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Lamb</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Oliva</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Zivanovic</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Juretzka</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Pirog</surname>
            <given-names>EC</given-names>
          </name>
          <article-title>Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus</article-title>
          <source>Am J Surg Pathol</source>
          <year>2011</year>
          <volume>35</volume>
          <fpage>633</fpage>
          <lpage>646</lpage>
          <pub-id pub-id-type="doi">10.1097/PAS.0b013e31821534b9</pub-id>
          <pub-id pub-id-type="pmid">21490443</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="book">
          <name>
            <surname>Atkins</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Hendrickson</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Kempson</surname>
            <given-names>RL</given-names>
          </name>
          <person-group person-group-type="editor">Mills SE</person-group>
          <article-title>Normal histology of the uterus and fallopian tubes</article-title>
          <source>Histology for pathologists</source>
          <year>2012</year>
          <edition>4</edition>
          <publisher-name>Philadelphia: Lippincott Williams &amp; Wilkins</publisher-name>
          <fpage>1071</fpage>
          <lpage>1117</lpage>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Huffman</surname>
            <given-names>JW</given-names>
          </name>
          <article-title>Mesonephric remnants in the cervix</article-title>
          <source>Am J Obstet Gynecol</source>
          <year>1948</year>
          <volume>56</volume>
          <fpage>23</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">18869717</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Fukunaga</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Takahashi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yasuda</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Mesonephric adenocarcinoma of the uterine cervix: a case report with immunohistochemical and ultrastructural studies</article-title>
          <source>Pathol Res Pract</source>
          <year>2008</year>
          <volume>204</volume>
          <fpage>671</fpage>
          <lpage>676</lpage>
          <pub-id pub-id-type="doi">10.1016/j.prp.2008.01.008</pub-id>
          <pub-id pub-id-type="pmid">18374498</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yap</surname>
            <given-names>OW</given-names>
          </name>
          <name>
            <surname>Hendrickson</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Teng</surname>
            <given-names>NN</given-names>
          </name>
          <name>
            <surname>Kapp</surname>
            <given-names>DS</given-names>
          </name>
          <article-title>Mesonephric adenocarcinoma of the cervix: a case report and review of the literature</article-title>
          <source>Gynecol Oncol</source>
          <year>2006</year>
          <volume>103</volume>
          <fpage>1155</fpage>
          <lpage>1158</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ygyno.2006.08.031</pub-id>
          <pub-id pub-id-type="pmid">17023031</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Garc&#xED;a-Espinosa</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Nieto-Bona</surname>
            <given-names>MP</given-names>
          </name>
          <name>
            <surname>Rueda</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Silva-S&#xE1;nchez</surname>
            <given-names>LF</given-names>
          </name>
          <name>
            <surname>Piernas-Morales</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Carro-Campos</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Cort&#xE9;s-Lambea</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Moro-Rodr&#xED;guez</surname>
            <given-names>E</given-names>
          </name>
          <article-title>Genotype distribution of cervical human papillomavirus DNA in women with cervical lesions in Bioko, Equatorial Guinea</article-title>
          <source>Diagn Pathol</source>
          <year>2009</year>
          <volume>4</volume>
          <fpage>31</fpage>
          <pub-id pub-id-type="doi">10.1186/1746-1596-4-31</pub-id>
          <pub-id pub-id-type="pmid">19740435</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Liu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer</article-title>
          <source>Diagn Pathol</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>147</fpage>
          <pub-id pub-id-type="doi">10.1186/1746-1596-7-147</pub-id>
          <pub-id pub-id-type="pmid">23107094</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Han</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>Z</given-names>
          </name>
          <article-title>Decreased D2-40 and increased p16INK4A immunoreactivities correlate with higher grade of cervical intraepithelial neoplasia</article-title>
          <source>Diagn Pathol</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>59</fpage>
          <pub-id pub-id-type="doi">10.1186/1746-1596-6-59</pub-id>
          <pub-id pub-id-type="pmid">21729305</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Buntine</surname>
            <given-names>DW</given-names>
          </name>
          <article-title>Adenocarcinoma of the uterine cervix of probable Wolffian origin</article-title>
          <source>Pathology</source>
          <year>1979</year>
          <volume>11</volume>
          <fpage>713</fpage>
          <lpage>718</lpage>
          <pub-id pub-id-type="doi">10.3109/00313027909059053</pub-id>
          <pub-id pub-id-type="pmid">530758</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Valente</surname>
            <given-names>PT</given-names>
          </name>
          <name>
            <surname>Susin</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Cervical adenocarcinoma arising in florid mesonephric hyperplasia: report of a case with immunocytochemical studies</article-title>
          <source>Gynecol Oncol</source>
          <year>1987</year>
          <volume>27</volume>
          <fpage>58</fpage>
          <lpage>68</lpage>
          <pub-id pub-id-type="doi">10.1016/0090-8258(87)90230-7</pub-id>
          <pub-id pub-id-type="pmid">2436982</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ferry</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Scully</surname>
            <given-names>RE</given-names>
          </name>
          <article-title>Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>1990</year>
          <volume>14</volume>
          <fpage>1100</fpage>
          <lpage>1111</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-199012000-00002</pub-id>
          <pub-id pub-id-type="pmid">2252101</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="other">
          <name>
            <surname>Anagnostopoulos</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ruthven</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kingston</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Mesonephric adenocarcinoma of the uterine cervix and literature review</article-title>
          <source>BMJ Case Rep</source>
          <year>2012</year>
          <fpage>&#x2009;</fpage>
          <pub-id pub-id-type="doi">10.1136/bcr.01.2012.5632</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
